492 related articles for article (PubMed ID: 25257637)
1. Efficacy of different beta-blockers in the treatment of long QT syndrome.
Abu-Zeitone A; Peterson DR; Polonsky B; McNitt S; Moss AJ
J Am Coll Cardiol; 2014 Sep; 64(13):1352-8. PubMed ID: 25257637
[TBL] [Abstract][Full Text] [Related]
2. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management.
Goldenberg I; Bradley J; Moss A; McNitt S; Polonsky S; Robinson JL; Andrews M; Zareba W;
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):893-901. PubMed ID: 20233272
[TBL] [Abstract][Full Text] [Related]
3. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol.
Chockalingam P; Crotti L; Girardengo G; Johnson JN; Harris KM; van der Heijden JF; Hauer RN; Beckmann BM; Spazzolini C; Rordorf R; Rydberg A; Clur SA; Fischer M; van den Heuvel F; Kääb S; Blom NA; Ackerman MJ; Schwartz PJ; Wilde AA
J Am Coll Cardiol; 2012 Nov; 60(20):2092-9. PubMed ID: 23083782
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis.
Ahn J; Kim HJ; Choi JI; Lee KN; Shim J; Ahn HS; Kim YH
PLoS One; 2017; 12(10):e0185680. PubMed ID: 29059199
[TBL] [Abstract][Full Text] [Related]
5. Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome.
Chatrath R; Bell CM; Ackerman MJ
Pediatr Cardiol; 2004; 25(5):459-65. PubMed ID: 15534720
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.
Moss AJ; Zareba W; Hall WJ; Schwartz PJ; Crampton RS; Benhorin J; Vincent GM; Locati EH; Priori SG; Napolitano C; Medina A; Zhang L; Robinson JL; Timothy K; Towbin JA; Andrews ML
Circulation; 2000 Feb; 101(6):616-23. PubMed ID: 10673253
[TBL] [Abstract][Full Text] [Related]
7. Clinical aspects of the three major genetic forms of long QT syndrome (LQT1, LQT2, LQT3).
Kutyifa V; Daimee UA; McNitt S; Polonsky B; Lowenstein C; Cutter K; Lopes C; Zareba W; Moss AJ
Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12537. PubMed ID: 29504689
[TBL] [Abstract][Full Text] [Related]
8. Risk of fatal arrhythmic events in long QT syndrome patients after syncope.
Jons C; Moss AJ; Goldenberg I; Liu J; McNitt S; Zareba W; Qi M; Robinson JL
J Am Coll Cardiol; 2010 Feb; 55(8):783-8. PubMed ID: 20170817
[TBL] [Abstract][Full Text] [Related]
9. Long QT syndrome and pregnancy.
Seth R; Moss AJ; McNitt S; Zareba W; Andrews ML; Qi M; Robinson JL; Goldenberg I; Ackerman MJ; Benhorin J; Kaufman ES; Locati EH; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
J Am Coll Cardiol; 2007 Mar; 49(10):1092-8. PubMed ID: 17349890
[TBL] [Abstract][Full Text] [Related]
10. Long QT syndrome in adults.
Sauer AJ; Moss AJ; McNitt S; Peterson DR; Zareba W; Robinson JL; Qi M; Goldenberg I; Hobbs JB; Ackerman MJ; Benhorin J; Hall WJ; Kaufman ES; Locati EH; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
J Am Coll Cardiol; 2007 Jan; 49(3):329-37. PubMed ID: 17239714
[TBL] [Abstract][Full Text] [Related]
11. Risk of Cardiac Events Associated With Antidepressant Therapy in Patients With Long QT Syndrome.
Wang M; Szepietowska B; Polonsky B; McNitt S; Moss AJ; Zareba W; Auerbach DS
Am J Cardiol; 2018 Jan; 121(2):182-187. PubMed ID: 29174490
[TBL] [Abstract][Full Text] [Related]
12. Frequency and severity of hypoglycemia in children with beta-blocker-treated long QT syndrome.
Poterucha JT; Bos JM; Cannon BC; Ackerman MJ
Heart Rhythm; 2015 Aug; 12(8):1815-9. PubMed ID: 25929701
[TBL] [Abstract][Full Text] [Related]
13. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome.
Hobbs JB; Peterson DR; Moss AJ; McNitt S; Zareba W; Goldenberg I; Qi M; Robinson JL; Sauer AJ; Ackerman MJ; Benhorin J; Kaufman ES; Locati EH; Napolitano C; Priori SG; Towbin JA; Vincent GM; Zhang L
JAMA; 2006 Sep; 296(10):1249-54. PubMed ID: 16968849
[TBL] [Abstract][Full Text] [Related]
14. An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia.
Peltenburg PJ; Kallas D; Bos JM; Lieve KVV; Franciosi S; Roston TM; Denjoy I; Sorensen KB; Ohno S; Roses-Noguer F; Aiba T; Maltret A; LaPage MJ; Atallah J; Giudicessi JR; Clur SB; Blom NA; Tanck M; Extramiana F; Kato K; Barc J; Borggrefe M; Behr ER; Sarquella-Brugada G; Tfelt-Hansen J; Zorio E; Swan H; Kammeraad JAE; Krahn AD; Davis A; Sacher F; Schwartz PJ; Roberts JD; Skinner JR; van den Berg MP; Kannankeril PJ; Drago F; Robyns T; Haugaa K; Tavacova T; Semsarian C; Till J; Probst V; Brugada R; Shimizu W; Horie M; Leenhardt A; Ackerman MJ; Sanatani S; van der Werf C; Wilde AAM
Circulation; 2022 Feb; 145(5):333-344. PubMed ID: 34874747
[TBL] [Abstract][Full Text] [Related]
15. Experience with bisoprolol in long-QT1 and long-QT2 syndrome.
Steinberg C; Padfield GJ; Al-Sabeq B; Adler A; Yeung-Lai-Wah JA; Kerr CR; Deyell MW; Andrade JG; Bennett MT; Yee R; Klein GJ; Green M; Laksman ZW; Krahn AD; Chakrabarti S
J Interv Card Electrophysiol; 2016 Nov; 47(2):163-170. PubMed ID: 27394160
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing.
Dorostkar PC; Eldar M; Belhassen B; Scheinman MM
Circulation; 1999 Dec; 100(24):2431-6. PubMed ID: 10595956
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome.
Goldenberg I; Moss AJ; Peterson DR; McNitt S; Zareba W; Andrews ML; Robinson JL; Locati EH; Ackerman MJ; Benhorin J; Kaufman ES; Napolitano C; Priori SG; Qi M; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
Circulation; 2008 Apr; 117(17):2184-91. PubMed ID: 18427136
[TBL] [Abstract][Full Text] [Related]
18. Risk of death in the long QT syndrome when a sibling has died.
Kaufman ES; McNitt S; Moss AJ; Zareba W; Robinson JL; Hall WJ; Ackerman MJ; Benhorin J; Locati ET; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
Heart Rhythm; 2008 Jun; 5(6):831-6. PubMed ID: 18534367
[TBL] [Abstract][Full Text] [Related]
19. Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study.
Wilde AA; Moss AJ; Kaufman ES; Shimizu W; Peterson DR; Benhorin J; Lopes C; Towbin JA; Spazzolini C; Crotti L; Zareba W; Goldenberg I; Kanters JK; Robinson JL; Qi M; Hofman N; Tester DJ; Bezzina CR; Alders M; Aiba T; Kamakura S; Miyamoto Y; Andrews ML; McNitt S; Polonsky B; Schwartz PJ; Ackerman MJ
Circulation; 2016 Sep; 134(12):872-82. PubMed ID: 27566755
[TBL] [Abstract][Full Text] [Related]
20. Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta(2) agonists.
Thottathil P; Acharya J; Moss AJ; Jons C; McNitt S; Goldenberg I; Zareba W; Kaufman E; Qi M; Robinson JL;
Am J Cardiol; 2008 Oct; 102(7):871-4. PubMed ID: 18805113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
